156 related articles for article (PubMed ID: 24755735)
1. Papillary thyroid microcarcinoma: proposal of treatment based on histological prognostic factors evaluation.
Ardito G; Avenia N; Giustozzi E; Salvatori M; Fadda G; Ardito F; Revelli L
Ann Ital Chir; 2014; 85(1):1-5. PubMed ID: 24755735
[TBL] [Abstract][Full Text] [Related]
2. Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.
Ardito G; Revelli L; Giustozzi E; Salvatori M; Fadda G; Ardito F; Avenia N; Ferretti A; Rampin L; Chondrogiannis S; Colletti PM; Rubello D
Clin Nucl Med; 2013 Jan; 38(1):25-8. PubMed ID: 23242040
[TBL] [Abstract][Full Text] [Related]
3. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
4. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
5. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes.
Sugitani I; Toda K; Yamada K; Yamamoto N; Ikenaga M; Fujimoto Y
World J Surg; 2010 Jun; 34(6):1222-31. PubMed ID: 20066418
[TBL] [Abstract][Full Text] [Related]
6. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
7. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
8. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
Cheema Y; Olson S; Elson D; Chen H
J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
[TBL] [Abstract][Full Text] [Related]
9. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience.
Cappelli C; Castellano M; Braga M; Gandossi E; Pirola I; De Martino E; Agosti B; Rosei EA
J Surg Oncol; 2007 Jun; 95(7):555-60. PubMed ID: 17226813
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience [corrected].
Al-Qahtani KH; Al Asiri M; Tunio MA; Aljohani NJ; Bayoumi Y; Fatani H; AlHadab A
J Otolaryngol Head Neck Surg; 2015 Dec; 44():51. PubMed ID: 26621255
[TBL] [Abstract][Full Text] [Related]
11. Incidental papillary thyroid microcarcinoma: is completion surgery required?
Muntean V; Domsa I; Zolog A; Piciu D; Fabian O; Bosu R; Simescu R; Petre G; Muntean MV
Chirurgia (Bucur); 2013; 108(4):490-7. PubMed ID: 23958091
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients.
Kim KJ; Kim SM; Lee YS; Chung WY; Chang HS; Park CS
Ann Surg Oncol; 2015 Jan; 22(1):125-31. PubMed ID: 25092159
[TBL] [Abstract][Full Text] [Related]
13. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
14. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
16. [Our experience with papillary microcarcinoma of the thyroid].
Garrel R; Cartier C; Marvaso V; Corpelet D; Makeieff M; Crampette L; Guerrier B
Rev Laryngol Otol Rhinol (Bord); 2002; 123(4):239-42. PubMed ID: 12723489
[TBL] [Abstract][Full Text] [Related]
17. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
18. Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: A retrospective study of 1,391 prospective documented patients.
Gschwandtner E; Klatte T; Swietek N; Bures C; Kober F; Ott J; Schultheis A; Neuhold N; Hermann M
Surgery; 2016 Feb; 159(2):503-11. PubMed ID: 26189948
[TBL] [Abstract][Full Text] [Related]
19. Incidental papillary microcarcinoma of the thyroid--further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up.
Neuhold N; Schultheis A; Hermann M; Krotla G; Koperek O; Birner P
Ann Surg Oncol; 2011 Nov; 18(12):3430-6. PubMed ID: 21431405
[TBL] [Abstract][Full Text] [Related]
20. Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.
Cupisti K; Lehwald N; Anlauf M; Riemer J; Werner TA; Krieg A; Witte J; Chanab A; Baldus SE; Krausch M; Raffel A; Herdter C; Schott M; Knoefel WT
Horm Metab Res; 2014 Feb; 46(2):138-44. PubMed ID: 24356791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]